Scarica l'app Stockscreener
1.61
5.85%
-0.10
Codexis Inc Borsa (CDXS) Ultime notizie
Codexis rises after Q4 beat, strong outlook - MSN
Codexis Faces Strategic Challenges Amidst Revenue Dip - timothysykes.com
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement - simplywall.st
Codexis (NASDAQ:CDXS) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year - AOL.com
Codexis Stock Plummets Amid Financial Struggles - StocksToTrade
Why did Codexis (CDXS) stock soar nearly 38% after hours? - MSN
Why did CDXS stock jump 7% today? - MSN
Cantor Fitzgerald Maintains Overweight on Codexis (CDXS) March 2026 - Meyka
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative - Sahm
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Sahm
Codexis (CDXS) Stock Jumps 2.4% Following Strong Q4 Earnings Report - MEXC
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance - Investing.com UK
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal By Investing.com - Investing.com South Africa
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Stock Rises 2.4% After Q4 Earnings Beat - MEXC
Crude Oil Surges Over 8%; Dollar General Shares Fall After Q4 Results - Benzinga
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance By Investing.com - Investing.com Canada
Codexis Shines as Q4 Profit Sparks Investor Enthusiasm - StocksToTrade
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal - Investing.com
Codexis Surpasses Q4 Expectations, Stock Price Volatility Anticipated - timothysykes.com
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Benzinga
Codexis (CDXS) Surges on Strong Q4 2025 Results and Optimistic O - GuruFocus
Codexis, Inc. (NASDAQ:CDXS) Q4 2025 Earnings Call Transcript - Insider Monkey
Codexis stock rises after Q4 beat, outlook (CDXS:NASDAQ) - Seeking Alpha
Codexis, Inc. 2025 Annual Report: Advancements in ECO Synthesis Platform and Pharma Biocatalysis for Therapeutics Manufacturing - Minichart
Codexis: Q4 Earnings Snapshot - theheraldreview.com
Codexis (CDXS) Expects Current Funds to Last Through 2027 - GuruFocus
Codexis Inc (CDXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Codexis, Inc. Q4 2025 Earnings Call Summary - finance.yahoo.com
Codexis (CDXS) beats Q4 earnings and revenue estimates - MSN
Codexis (CDXS) Q4 2025 Earnings Call Transcript - The Globe and Mail
Codexis (CDXS) Surpasses Q4 Expectations for Earnings and Revenue - Bitget
Earnings call transcript: Codexis Surpasses Q4 2025 Expectations with Strong Revenue Growth - Investing.com Canada
CDXS: Strong 2025 revenue and ECO Synthesis progress set the stage for continued growth in 2026 - TradingView
Codexis Q4 Earnings Call Highlights - Yahoo Finance
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Codexis (NASDAQ: CDXS) doubles down on ECO Synthesis RNAi platform amid 2025 loss - Stock Titan
Codexis (CDXS) Exceeds Revenue Expectations, Highlights Technolo - GuruFocus
Codexis Q4 2025 Results: $9.6M Profit, 2026 Revenue Forecast $72M-$76MNews and Statistics - IndexBox
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Codexis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Codexis 2025 10-K: Revenue $70.4M, EPS $(0.50) - TradingView
CDXS: Revenue rose 19% to $70.4M, net loss narrowed, and ECO Synthesis platform advanced - TradingView
Codexis (NASDAQ:CDXS) Releases Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
CODEXIS ($CDXS) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Codexis Q4 Swings to Profit, Revenue Rises - marketscreener.com
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results - The Manila Times
Codexis (NASDAQ: CDXS) grows 2025 revenue, trims loss and secures $37.8M Merck deal - Stock Titan
Codexis swings to Q4 profit as Merck deal lifts revenue and funds RNAi push - Stock Titan
Laurence Lytton holds 4.53M shares at Codexis (NASDAQ: CDXS) - Stock Titan
Preview: Codexis's Earnings - Benzinga
Codexis signs deal to produce siRNA for pharma partner - Investing.com Nigeria
Codexis Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Codexis Targets 2026 Inflection as CEO Touts ECO Synthesis Push in RNA Manufacturing at TD Cowen Conf - MarketBeat
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):